Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127785601 | 12778560 | 1 | I | 20160913 | 20160926 | 20160926 | EXP | AU-APOTEX-2016AP012192 | APOTEX | NGUYEN TA, CAUGHEY G, PRATT N, SHAKIB S, KEMP A, ROUGHEAD E.. HOSPITALIZATION FOR DRUG-INDUCED HEPATOTOXICITY: LINKING Y-CODES WITH PHARMACEUTICAL CLAIMS DATA TO IDENTIFY IMPLICATED MEDICINES.. J-CLIN-PHARM-THER. 2015;40(2):213-219 | 0.00 | Y | 0.00000 | 20160926 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127785601 | 12778560 | 1 | SS | AMOXICILLIN. | AMOXICILLIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 127785601 | 12778560 | 2 | SS | CEFACLOR. | CEFACLOR | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 127785601 | 12778560 | 3 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK | U | U | 0 | TABLET | |||||||
| 127785601 | 12778560 | 4 | SS | RAMIPRIL. | RAMIPRIL | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 127785601 | 12778560 | 5 | PS | APO-ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK | U | U | 90548 | TABLET | |||||||
| 127785601 | 12778560 | 6 | SS | AMOXICILLIN, CLAVULANATE | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 127785601 | 12778560 | 7 | SS | APOHEALTH CARDIO ASPIRIN | ASPIRIN | 1 | Unknown | UNK | U | U | 0 | TABLET | |||||||
| 127785601 | 12778560 | 8 | SS | INDOMETACIN | INDOMETHACIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 127785601 | 12778560 | 9 | SS | GLIBENCLAMIDE | GLYBURIDE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127785601 | 12778560 | 1 | Product used for unknown indication |
| 127785601 | 12778560 | 2 | Product used for unknown indication |
| 127785601 | 12778560 | 3 | Product used for unknown indication |
| 127785601 | 12778560 | 4 | Product used for unknown indication |
| 127785601 | 12778560 | 5 | Product used for unknown indication |
| 127785601 | 12778560 | 6 | Product used for unknown indication |
| 127785601 | 12778560 | 7 | Product used for unknown indication |
| 127785601 | 12778560 | 8 | Product used for unknown indication |
| 127785601 | 12778560 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127785601 | 12778560 | HO |
| 127785601 | 12778560 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127785601 | 12778560 | Drug-induced liver injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |